> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Peanut Allergen Powder
- URL: https://www.fdaweb.com/panel-to-review-peanut-allergen-powder/
- Published: 2019-06-24T12:00:00.000Z
- Updated: 2026-09-15T01:34:30.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144403

*Federal Register* notice: FDA has announced a 9/13 Allergenic Products Advisory Committee meeting. The panel is scheduled to discuss and make recommendations on the safety and efficacy of Peanut \[*Arachis hypogaea*\] Allergen Powder manufactured by Aimmune Therapeutics, indicated for reducing the risk of anaphylaxis after accidental exposure to peanuts in patients aged four to 17 years. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-06-24/pdf/2019-13354.pdf?ref=fdaweb.com).